Skip to main content
. 2009 Nov 6;28(1):143. doi: 10.1186/1756-9966-28-143

Table 3.

Immunoreactivity of VEGF, and the number of patients

Category Number of patients (%) alive/dead
Percentage of positive
tumour cells (P)
 <1% 2 (3.6%) 2/0
 1-25% 25 (44.6%) 17/8
 26-50% 18 (32.1%) 10/8
 51-75% 7 (12.5%) 4/3
 76-100% 4 (7.1%) 2/2
Staining intensity (I)
 Negative 2 (3.6%) 2/0
 Weak 11 (19.6%) 10/1
 Moderate 24 (42.9%) 12/12
 Strong 19 (33.9%) 11/8
Expression score (P+I)
 Low (0-2) 12 (21.4%) 12/0
 High (3-7) 44 (78.6%) 23/21